A clinical trial conducted by Dartmouth researchers has shown the potential of a generative AI-powered therapy chatbot, known as Therabot, in improving the mental health of individuals with conditions like depression, anxiety, and eating disorders
The results, published on March 27 in NEJM AI, revealed significant improvements in the participants’ symptoms after using the chatbot for just eight weeks.
Therapy chatbot
The study involved 106 individuals across the United States, all diagnosed with major depressive disorder, generalised anxiety disorder, or an eating disorder.
Participants interacted with Therabot through a smartphone app, responding to prompts about their feelings or starting conversations when they needed to talk. Throughout the trial,…